Enablers and Barriers to Prostate Cancer Screening in Africa: A Critical Narrative Review of Individual, Sociocultural and Health-System Determinants

Abstract

Prostate cancer is a major and increasing cause of cancer morbidity and mortality among African men, yet the value of early detection depends on more than whether a prostate-specific antigen test is available. Screening decisions are shaped by knowledge, perceived susceptibility, fear, masculinity, family and community norms, affordability, provider recommendation, service organisation and the capacity to complete diagnostic and treatment pathways after an abnormal result. This critical narrative review synthesises evidence on enablers and barriers to prostate cancer screening and early detection across Africa and evaluates how determinants at individual, interpersonal, community and health-system levels interact. Literature published from 1 January 2000 to 19 July 2026 was considered, with emphasis on peer-reviewed African studies and contextual use of high-quality international guidance. Across countries, awareness of prostate cancer is often higher than accurate knowledge of screening, and stated willingness commonly exceeds completed screening. Recurrent barriers include low perceived risk while asymptomatic, misconceptions, fear of diagnosis, fatalism, concerns about digital rectal examination, stigma, cost, lack of insurance, distance, weak continuity of care and absent provider recommendation. Enablers include clinician advice, trusted community messengers, family support, culturally adapted education, affordable or free services, proximity, health-worker engagement and navigation through follow-up. The intervention literature is encouraging but methodologically limited: most studies measure knowledge, intention or short-term uptake rather than stage shift, diagnostic completion, treatment receipt, harms, cost-effectiveness or mortality. A central finding is that screening uptake should not be treated as an isolated endpoint. Programmes are most defensible when informed choice and risk assessment are coupled to reliable referral, biopsy, pathology, staging and treatment capacity. African early-detection policy therefore requires locally evaluated, pathway-ready approaches rather than uncritical expansion of test volume. Priority research should compare risk-adapted delivery models, quantify downstream outcomes and harms, and test financing, provider-prompt, navigation and community-engagement strategies in diverse African settings.